J. A. Rump - Concepedia

Author

J. A. Rump

University of Freiburg

Also Known As

J A RUMP, J A Rump, J-A RUMP, J. A. Rump, J.-A. Rump, J.A Rump, J.A. Rump, J.‐A. Rump

Publications

377

Citations

H-Index

Concepts

All Affiliations

University of Freiburg University Medical Center Freiburg

About

J. A. Rump is an author at University of Freiburg specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	300
2	Education	1	1	82
3	Health Sciences	1	1	108
4	Allergy	1	1	18
5	Gastroenterology	1	1	48

J. A. Rump

Publications

318

Citations

H-Index

Page 1

	Year	Citations
Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation W Grotz, Marie K Breitenfeldt, P. Schollmeyer, Transplant International Molecular PharmacologyPain SyndromeHealth SciencesPain MedicinePharmacology	2001	108
Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum J. A. Rump, R. Arndt, Amber Arnold, Journal of Molecular Medicine Animal ScienceImmunologyVeterinary ScienceSerologic TestingVirology	1992	82
Intestinal B cell defects in common variable immunodeficiency Eberhard W. Herbst, Martin Armbruster, J. A. Rump, Clinical & Experimental Immunology Primary ImmunodeficiencyPlasma CellsAutoimmune DiseaseMedicineImmunology	1994	48
Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency J. A. Rump, Angelika Jahreis, Michael Schlesier, Clinical & Experimental Immunology ImmunodeficienciesImmunologyImmune RegulationPathologyCommon Variable Immunodeficiency	1992	33
Two novel cationic staphylococcal proteins induce IL-2 secretion, proliferation and immunoglobulin synthesis in peripheral blood mononuclear cells (PBMC) of both healthy controls and patients with common variable immunodeficiency (CVID) Angelika Jahreis, Yehia Yousif, J. A. Rump, Clinical & Experimental Immunology ImmunodeficienciesIl-2 StimulationImmunologyImmune RegulationStaphylococcus Aureus	1995	18
A double blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID) J. A. Rump, Angelika Jahreis, Michael Schlesier, Clinical & Experimental Immunology	1997	18
Leukocytoclastic vasculitis and long-term remission in a patient with secondary AML and post-remission treatment with low-dose interleukin-2 Monika Engelhardt, J. A. Rump, U Hellerich, Annals of Hematology InflammationSecondary AmlPost-remission TreatmentBone Marrow FailureVasculitis	1995	11

Page 1